Middlesex Hospital
Middletown, Connecticut, United States
General hospital in Middletown, Connecticut
28 Crescent St, Middletown, CT 06457
About Middlesex Hospital
"Middlesex Hospital at Middlesex Health: world-class medical technology, Magnet nurses, and some of Connecticut’s highest quality and patient satisfaction ratings."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
39
Alliance for Clinical Trials in Oncology
10
SWOG Cancer Research Network
9
ECOG-ACRIN Cancer Research Group
4
Exact Sciences Corporation
3
Academic and Community Cancer Research United
2
Gynecologic Oncology Group
2
NSABP Foundation Inc
2
Alliance Foundation Trials, LLC.
1
Intuitive Surgical
1
NRG Oncology
1
Clinical Trials at Middlesex Hospital
During the past decade, Middlesex Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 34 clinical trials were completed, i.e. on
average, 106.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 17 clinical trials were completed. i.e. 850%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
2000-12-01
2014-11-01
Terminated
748
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
2005-08-15
2017-11-28
Completed
188
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
2008-05-15
Active, not recruiting
394
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Middlesex Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials
sponsored, "SWOG Cancer Research Network" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Exact Sciences Corporation"
with 4 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Middlesex Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 21 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at Middlesex Hospital
According to Clinical.Site data, the most researched conditions in "Middlesex Hospital" are
"Recurrent Breast Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (7 trials), "Stage IIIB Breast Cancer AJCC v7" (6 trials), "Stage IIIC Breast Cancer AJCC v7" (6 trials) and "Breast Adenocarcinoma" (5 trials). Many other conditions were trialed in "Middlesex Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Middlesex Hospital
Most popular intervention types in "Middlesex Hospital" are "Drug" (60 trials), "Other" (57 trials), "Biological" (23 trials), "Procedure" (11 trials) and "Radiation" (9 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (19 trials), "Paclitaxel" (13 trials), "Carboplatin" (8 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Middlesex Hospital
The vast majority of trials in "Middlesex Hospital" are
58 trials for "All" genders, 17 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Middlesex Hospital
Currently, there are NaN active trials in "Middlesex Hospital".
undefined are not yet recruiting,
9 are recruiting,
43 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Middlesex Hospital,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Middlesex Hospital, 0 "Phase 1"
clinical trials were conducted, 23 "Phase 2" clinical
trials and 46 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of Middlesex Hospital
Middlesex Hospital has several departments that took part in Clinical trials: "Middlesex Hospital Cancer Center" - 17 trials
Departments List
Name
City
Trials